The CD73-adenosine axis in melanoma: from multidimensional regulation to precision immunotherapy
The therapeutic landscape of advanced melanoma has been transformed by immune checkpoint inhibitors (ICIs); however, primary and acquired resistance remain formidable challenges for a substantial subset of patients. Emerging evidence identifies the CD7…